BHA FPX 4020 Assessment 2 Health Care Professional Feedback

• BHA FPX 4020 Assessment 2

Health Care Professional Feedback

The Value of Feedback from Healthcare Professionals

Incorporating healthcare professionals’ feedback during healthcare projects’ planning and implementation phases ensures alignment with real-world needs and maximises success. Their insights provide a vital connection between proposed interventions and the realities of healthcare delivery (Kneck et al., 2019). This proposal highlights the importance of engaging health professionals to refine strategies aimed at reducing readmissions related to opioid use.

Introduction and Identification of Health Care Professionals

Selecting the Right Professional

To gain expert endorsement for the capstone project, I sought feedback from Dr. Maurizio Fava, Chief of Psychiatry at Massachusetts General Hospital. Dr. Fava’s extensive experience and influence within the organization made him a valuable contributor to the project’s direction.

Initial Contact

Establishing Communication

The initial contact was made through a formal email introducing the project’s goals and seeking Dr. Fava’s input. Below is an excerpt from the email:

Dear Dr. Fava,

My name is XYZ. I am an undergraduate Healthcare Management student at Capella University. I am currently working on my capstone project, part of the BHA FPX 4020 Assessment 2, which focuses on addressing the high rate of hospital readmissions due to opioid use.

The project aims to identify solutions based on organisational data and develop actionable strategies to improve patient outcomes. I hope to incorporate your expertise to refine the proposal.

Thank you for considering my request. I look forward to collaborating with you.

Best regards,
XYZ

Project Proposal

The Challenge of Opioid Readmissions

Opioid misuse is a significant public health issue in the United States, leading to increased hospital readmissions and substantial economic costs. According to Mejia de Grubb et al. (2019), patients with opioid-related diagnoses are 20% more likely to be readmitted within 30 days than those with other conditions.

Economic Burden of Opioid Misuse

The Pew Charitable Trusts estimated that the annual economic impact of prescription opioid misuse exceeds $140 billion, encompassing healthcare expenses, lost productivity, and criminal justice costs (Pew, 2021). Addressing this crisis is critical to reducing the burden on healthcare systems and improving patient care.

Evidence-Based Strategies

Pain Management Alternatives

Holistic pain management strategies, including physical therapy, cognitive-behavioural therapy, and non-opioid medications, can reduce reliance on opioids. Training healthcare providers in appropriate prescribing practices minimise overprescription (Gupta et al., 2020).

Medication-Assisted Treatment (MAT)

MAT combines medications like buprenorphine or methadone with counselling and behavioural therapies. Maglione et al. (2020) emphasise expanding access to these treatments to improve recovery rates and prevent relapse.

Interdisciplinary Collaboration

Enhanced collaboration among primary care physicians, addiction specialists, mental health providers, and pharmacists ensures comprehensive care for patients with opioid use disorders (Humensky et al., 2019).

Prescription Drug Monitoring Programs (PDMPs)

Integrating PDMPs with electronic health records allows healthcare providers to track opioid prescriptions effectively, reducing misuse and improving patient safety (Al-Astal et al., 2022).

Prospective Impacts and Recommendations

Improved Outcomes

Implementing these strategies can significantly reduce opioid-related readmissions, improve patient outcomes, and alleviate the burden on healthcare systems. PDMPs and MAT programs offer promising solutions for addressing opioid misuse and enhancing care quality.

Adapting Based on Feedback

Feedback from healthcare professionals, particularly Dr Fava, emphasised the importance of telehealth in improving access to care. Integrating telemedicine allows for continuous follow-up and monitoring, especially for patients in rural areas or with mobility challenges (Haleem et al., 2021).

Approval and Implementation

Project Approval

The project received approval within a week of submission. Clear guidelines were established to protect patient data and ensure compliance with confidentiality rules. The project also included specific roles for assessment and execution teams to streamline implementation.

Conclusion

Feedback from healthcare professionals, including Dr. Fava, played a pivotal role in refining this capstone project. By incorporating their recommendations, such as telehealth services and interdisciplinary collaboration, the project effectively addresses the complex challenges of opioid use disorder.

This proposal, developed as part of BHA FPX 4020 Assessment 2, aims to reduce readmissions and improve patient care outcomes by leveraging evidence-based strategies and professional insights.

Read more about our sample BHA FPX 4020 Assessment 1 Health Care Problem Analysis Proposal for complete information about this class.

References

Al-Astal, A.-E. Y., Sodhi, K., & Lakhani, H. V. (2022). Optimisation of a prescription drug monitoring program to overcome the opioid epidemic in West Virginia. Cureus.

https://doi.org/10.7759/cureus.22434 

Dickson-Gomez, J., Christenson, E., Weeks, M., Galletly, C., Wogen, J., Spector, A., McDonald, M., & Ohlrich, J. (2021). Effects of implementation and enforcement differences in prescription drug monitoring programs in 3 states: Connecticut, Kentucky, and Wisconsin. Substance Abuse: Research and Treatment, 15.

https://doi.org/10.1177/1178221821992349 

Dydyk, A. M., Jain, N. K., & Gupta, M. (2022). Opioid use disorder. PubMed; StatPearls Publishing.

https://www.ncbi.nlm.nih.gov/books/NBK553166/ 

Gupta, A., Lindstrom, S., & Shevatekar, G. (2020). Reducing opioid overprescribing by educating, monitoring and collaborating with clinicians: A quality improvement study. Cureus.

https://doi.org/10.7759/cureus.7778 

Huecker, M. R., Azadfard, M., & Leaming, J. M. (2019, February 28). Opioid addiction. Nih.gov; StatPearls Publishing.

https://www.ncbi.nlm.nih.gov/books/NBK448203/ 

Haleem, A., Javaid, M., Singh, R. P., & Suman, R. (2021). Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sensors International, 2(2).

https://doi.org/10.1016/j.sintl.2021.100117 

Humensky, J. L., Abedin, Z., Muhammad, K., McClave, M., Torres, T., DiMaria, E. S., Reilly, M. P., & Pincus, H. A. (2019). Promoting interdisciplinary research to respond to public health crises: The response of the Columbia University CTSA to the opioid crisis. Journal of Clinical and Translational Science, 4(1), 22–27.

https://doi.org/10.1017/cts.2019.426 

Kneck, Å., Flink, M., Frykholm, O., Kirsebom, M., & Ekstedt, M. (2019). The information flow in a healthcare organisation with integrated units. International Journal of Integrated Care, 19(3).

https://doi.org/10.5334/ijic.4192 

Maglione, M. A., Raaen, L., Chen, C., Azhar, G. S., Nima, S., Shen, M., Hernandez, E. J. M., Shanman, R. M., & Hempel, S. (2020). Effects of Medication-Assisted Treatment (MAT) for opioid use disorder on functional outcomes: A systematic review. Rand Health Quarterly, 8(4).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302321/# 

Mejia de Grubb, M. C., Salemi, J. L., Gonzalez, S. J., Chima, C. C., Kowalchuk, A. A., & Zoorob, R. J. (2019). Opioid, cocaine, and amphetamine use disorders are associated with higher 30-day inpatient readmission rates in the United States. Substance Abuse, 41(3), 365–374.

https://doi.org/10.1080/08897077.2019.1635964 

Pew. (2021). The high price of the opioid Crisis, 2021. Pew.org.

https://www.pewtrusts.org/en/research-and-analysis/data-visualizations/2021/the-high-price-of-the-opioid-crisis-2021 

Volkow, N. D., & Blanco, C. (2020). The changing opioid crisis: Development, challenges, and opportunities. Molecular Psychiatry, 26(1), 1–16.

https://doi.org/10.1038/s41380-020-0661-4